Back to search
Atherosclerosis of the Peripheral Arteries
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atherosclerosis of the Peripheral Arteries trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Atherosclerosis of the Peripheral Arteries trials you may qualify forThe objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® in treatment…
This study is an investigator-initiated, prospective, single-center, 1:1 randomized pilot study. The trial evaluates the safety and efficacy of intravascular l…
To compare the efficacy and safety of stent angioplasty with Orchid 035 Drug Coated Dilatation (DCB) and Plain Old Balloon Angioplasty (POBA) for post-dilatatio…
To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes
This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a dose-finding…
The study is a Phase 2a, randomized, double-blind, placebo-controlled, sequential cohort study to evaluate the pharmacodynamics (PD), safety and pharmacokinetic…
Peripheral arterial disease (PAD) can progress to critical limb ischemia (CLI) of the affected lower limb, characterized by pain at rest, ulcerations or gangren…
This clinical trial will evaluate the study device, Passeo®-18 Lux® paclitaxel-releasing percutaneous transluminal angioplasty (PTA) balloon catheter for the tr…